Application 761440
- Type
- BLA
- Sponsor
- GLAXOSMITHKLINE LLC
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761440 | Blenrep | belantamab mafodotin-blmf | 351(a) | Rx | 2026-10-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | BLENREP | BELANTAMAB MAFODOTIN-BLMF | INJECTABLE;INJECTION | 70MG | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 83926 | ORIG | 2025-10-27 |
| 83912 | ORIG | 2025-10-24 |